Biomedical research infrastructure through establishing biomedical research programs in health and health disparities that are critical to the area. Four major cores are highlighted: research infrastructure and capacity building, strengthening faculty research and training, shared resources, and an administration. The cores synergistically build together to meet three overall objectives: 1. building the research capacity and capabilities for faculty, graduate, and undergraduate students, while emphasizing structured training, mentoring, and research partnerships with experienced biomedical research institutions in the area, 2. promoting and expanding specific biomedical research projects in health and health disparity issues in California's Central Valley through increasing collaborations between Fresno State faculty and faculty at research institutions in the area, and 3. enhancing research infrastructure facilities at Fresno State in the areas of proteomics and molecular and functional imaging to support and extend biomedical research activities in the Central Valley. The first and second objectives will be accomplished through further development of mentoring and collaborating relationships Fresno State faculty have already established with major biomedical research institutions in the area. The six faculty participants, drawn from the Departments of Chemistry, Biology, and Psychology, will carry out three collaborative subprojects in health related topics that are of particular importance to underserved populations in the Central Valley of California. The third objective, improvement of research infrastructure facilities, will be accomplished by renovating space to build two new laboratories. The proteomics/functional genomics laboratory and the molecular and functional imaging laboratory are being developed along with necessary informational management and biostatistics support. These research facilities critical for successful completion of the pilot projects, have strong institutional support in the way of matching funds, and will provide students and faculty with the resources and training necessary to develop productive careers in biomedical research. The university is currently focused on hiring talented new faculty, including faculty from groups traditionally underrepresented in the sciences, and the improvement of research infrastructure facilities is designed to further enhance our progress in this area. These new facilities will significantly add to the research capacity for several faculty members in the College of Science and Mathematics. The Fresno State RIMI program will be directed and administered by an office consisting of the PI (Provost), two Program co-Directors, one with emphasis on biomedical research and another with emphasis on behavioral science and a Program Manager (100%). The PI, PDs and the Core-leaders will work with an advisory committee of experts (4 from Fresno State and 6 from collaborating institutions) to provide strong leadership and assure that the program stays on course, meets research goals, and fulfills the needs of research faculty and collaborating mentors as provided by the program. Moreover, the PDs and Core-leaders have common research interests and personal research involvements in the planned activities. This will add considerable strength to their leadership, significantly increasing positive outcomes. Formative and summative evaluation of the program performance will be analyzed by the included evaluation plan. The Fresno State-RIMI program will offer a great opportunity for expediting Fresno State's institutional goal of becoming a premier campus in research and research training among comprehensive universities, and a model minority institution for addressing health and health-related disparity issues in California's Central Valley.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Exploratory Grants (P20)
Project #
5P20MD002732-05
Application #
8121566
Study Section
Special Emphasis Panel (ZMD1-RN (10))
Program Officer
Hunter, Deloris
Project Start
2007-09-30
Project End
2014-07-31
Budget Start
2011-08-08
Budget End
2014-07-31
Support Year
5
Fiscal Year
2011
Total Cost
$805,571
Indirect Cost
Name
California State University Fresno
Department
Type
Other Domestic Higher Education
DUNS #
793751087
City
Fresno
State
CA
Country
United States
Zip Code
93726
Calderón-Urrea, Alejandro; Vanholme, Bartel; Vangestel, Sandra et al. (2016) Early development of the root-knot nematode Meloidogyne incognita. BMC Dev Biol 16:10
Mani, Akshay; Ravindran, Resmi; Mannepalli, Soujanya et al. (2015) Data mining strategies to improve multiplex microbead immunoassay tolerance in a mouse model of infectious diseases. PLoS One 10:e0116262
Kumar, Arun V; Ali, Rehana F M; Cao, Yu et al. (2015) Application of data mining tools for classification of protein structural class from residue based averaged NMR chemical shifts. Biochim Biophys Acta 1854:1545-52
Xiong, Pahoua; Wang, Rubing; Zhang, Xiaojie et al. (2015) Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents. Anticancer Agents Med Chem 15:1197-203
Krishnan, V V; Ravindran, Resmi; Wun, Ted et al. (2014) Multiplexed measurements of immunomodulator levels in peripheral blood of healthy subjects: Effects of analytical variables based on anticoagulants, age, and gender. Cytometry B Clin Cytom 86:426-35
Heisel, Kurt A; Krishnan, V V (2014) NMR based solvent exchange experiments to understand the conformational preference of intrinsically disordered proteins using FG-nucleoporin peptide as a model. Biopolymers 102:69-77
Chen, Qiao-Hong; Kingston, David G I (2014) Zampanolide and dactylolide: cytotoxic tubulin-assembly agents and promising anticancer leads. Nat Prod Rep 31:1202-26
Samaan, Nawras; Zhong, Qiu; Fernandez, Jayjoel et al. (2014) Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents. Eur J Med Chem 75:123-31
Ravindran, Resmi; Krishnan, Viswanathan V; Khanum, Azra et al. (2013) Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients. Clin Vaccine Immunol 20:1283-90
Krishnan, V V; Murali, Nagarajan (2013) Radiation damping in modern NMR experiments: progress and challenges. Prog Nucl Magn Reson Spectrosc 68:41-57

Showing the most recent 10 out of 14 publications